Proactiveinvestors USA & Canada Bristol-Myers Squibb Co http://www.proactiveinvestors.com Proactiveinvestors USA & Canada Bristol-Myers Squibb Co RSS feed en Mon, 18 Jan 2021 00:10:10 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) US stocks close sharply higher as Biden and Trump await their fates http://www.proactiveinvestors.com/companies/news/933258/us-stocks-close-sharply-higher-as-biden-and-trump-await-their-fates-933258.html Thu, 05 Nov 2020 21:10:00 -0500 http://www.proactiveinvestors.com/companies/news/933258/us-stocks-close-sharply-higher-as-biden-and-trump-await-their-fates-933258.html Baird analysts stay Neutral on biotech sector as 2019 gets underway http://www.proactiveinvestors.com/companies/news/211977/baird-analysts-stay-neutral-on-biotech-sector-as-2019-gets-underway-211977.html Fri, 04 Jan 2019 14:24:00 -0500 http://www.proactiveinvestors.com/companies/news/211977/baird-analysts-stay-neutral-on-biotech-sector-as-2019-gets-underway-211977.html Bristol-Myers Squibb shares fall after FDA delays approval for lung cancer therapy http://www.proactiveinvestors.com/companies/news/207592/bristol-myers-squibb-shares-fall-after-fda-delays-approval-for-lung-cancer-therapy-207592.html Mon, 22 Oct 2018 16:23:00 -0400 http://www.proactiveinvestors.com/companies/news/207592/bristol-myers-squibb-shares-fall-after-fda-delays-approval-for-lung-cancer-therapy-207592.html Bristol-Myers Squibb's 2Q earnings beat Street on healthy sales of its blockbuster cancer drug Opdivo http://www.proactiveinvestors.com/companies/news/201677/bristol-myers-squibb-s-2q-earnings-beat-street-on-healthy-sales-of-its-blockbuster-cancer-drug-opdivo-201677.html Thu, 26 Jul 2018 16:05:00 -0400 http://www.proactiveinvestors.com/companies/news/201677/bristol-myers-squibb-s-2q-earnings-beat-street-on-healthy-sales-of-its-blockbuster-cancer-drug-opdivo-201677.html Cancer doctors offer key takeaways from American Society of Clinical Oncology conference http://www.proactiveinvestors.com/companies/news/198734/cancer-doctors-offer-key-takeaways-from-american-society-of-clinical-oncology-conference-198734.html Tue, 12 Jun 2018 20:44:00 -0400 http://www.proactiveinvestors.com/companies/news/198734/cancer-doctors-offer-key-takeaways-from-american-society-of-clinical-oncology-conference-198734.html Bristol Myers Squibb showcases positive results of new Phase 3 study evaluating cancer drug Opdivo http://www.proactiveinvestors.com/companies/news/198190/bristol-myers-squibb-showcases-positive-results-of-new-phase-3-study-evaluating-cancer-drug-opdivo-198190.html Mon, 04 Jun 2018 12:40:00 -0400 http://www.proactiveinvestors.com/companies/news/198190/bristol-myers-squibb-showcases-positive-results-of-new-phase-3-study-evaluating-cancer-drug-opdivo-198190.html Bristol-Myers beats 1Q estimates, guides higher for full-year 2018 on drug approvals http://www.proactiveinvestors.com/companies/news/195861/bristol-myers-beats-1q-estimates-guides-higher-for-full-year-2018-on-drug-approvals-195861.html Thu, 26 Apr 2018 12:40:00 -0400 http://www.proactiveinvestors.com/companies/news/195861/bristol-myers-beats-1q-estimates-guides-higher-for-full-year-2018-on-drug-approvals-195861.html Bristol-Myers falls after Citi analyst says Pfizer not interested in buying the drugmaker http://www.proactiveinvestors.com/companies/news/194888/bristol-myers-falls-after-citi-analyst-says-pfizer-not-interested-in-buying-the-drugmaker-194888.html Thu, 12 Apr 2018 18:00:00 -0400 http://www.proactiveinvestors.com/companies/news/194888/bristol-myers-falls-after-citi-analyst-says-pfizer-not-interested-in-buying-the-drugmaker-194888.html Bristol-Myers Squibb’s new dosing for cancer drug Opdivo gets FDA green light http://www.proactiveinvestors.com/companies/news/192680/bristol-myers-squibbs-new-dosing-for-cancer-drug-opdivo-gets-fda-green-light-192680.html Tue, 06 Mar 2018 12:49:00 -0500 http://www.proactiveinvestors.com/companies/news/192680/bristol-myers-squibbs-new-dosing-for-cancer-drug-opdivo-gets-fda-green-light-192680.html Bristol-Myers shares on the uptick after positive lung cancer trial results and market beating fourth quarter results http://www.proactiveinvestors.com/companies/news/191155/bristol-myers-shares-on-the-uptick-after-positive-lung-cancer-trial-results-and-market-beating-fourth-quarter-results-191155.html Mon, 05 Feb 2018 13:04:00 -0500 http://www.proactiveinvestors.com/companies/news/191155/bristol-myers-shares-on-the-uptick-after-positive-lung-cancer-trial-results-and-market-beating-fourth-quarter-results-191155.html Bristol-Myers Squibb drops on surprise third quarter profits miss http://www.proactiveinvestors.com/companies/news/186278/bristol-myers-squibb-drops-on-surprise-third-quarter-profits-miss-186278.html Thu, 26 Oct 2017 12:37:00 -0400 http://www.proactiveinvestors.com/companies/news/186278/bristol-myers-squibb-drops-on-surprise-third-quarter-profits-miss-186278.html Bristol Myers Squibb kidney cancer treatment meets endpoint of late-stage trial http://www.proactiveinvestors.com/companies/news/183617/bristol-myers-squibb-kidney-cancer-treatment-meets-endpoint-of-late-stage-trial-183617.html Thu, 07 Sep 2017 13:31:00 -0400 http://www.proactiveinvestors.com/companies/news/183617/bristol-myers-squibb-kidney-cancer-treatment-meets-endpoint-of-late-stage-trial-183617.html Bristol Myers Squibb buoyed by surge in sales of key drugs http://www.proactiveinvestors.com/companies/news/177002/bristol-myers-squibb-buoyed-by-surge-in-sales-of-key-drugs-177002.html Thu, 27 Apr 2017 13:07:00 -0400 http://www.proactiveinvestors.com/companies/news/177002/bristol-myers-squibb-buoyed-by-surge-in-sales-of-key-drugs-177002.html Bristol-Myers enters into two license deals with Biogen and Roche worth up to US$1.1bn http://www.proactiveinvestors.com/companies/news/176452/bristol-myers-enters-into-two-license-deals-with-biogen-and-roche-worth-up-to-us11bn-176452.html Thu, 13 Apr 2017 12:48:00 -0400 http://www.proactiveinvestors.com/companies/news/176452/bristol-myers-enters-into-two-license-deals-with-biogen-and-roche-worth-up-to-us11bn-176452.html Bristol-Myers shares hit by new lung cancer disappointment http://www.proactiveinvestors.com/companies/news/171953/bristol-myers-shares-hit-by-new-lung-cancer-disappointment-171953.html Fri, 20 Jan 2017 13:57:00 -0500 http://www.proactiveinvestors.com/companies/news/171953/bristol-myers-shares-hit-by-new-lung-cancer-disappointment-171953.html Bristol-Myers announces results for Opdivo http://www.proactiveinvestors.com/companies/news/170069/bristol-myers-announces-results-for-opdivo-170069.html Tue, 06 Dec 2016 21:26:00 -0500 http://www.proactiveinvestors.com/companies/news/170069/bristol-myers-announces-results-for-opdivo-170069.html Bristol Myers slumps as immunotherapy drug fails lung cancer trial http://www.proactiveinvestors.com/companies/news/129072/bristol-myers-slumps-as-immunotherapy-drug-fails-lung-cancer-trial-129072.html Fri, 05 Aug 2016 14:02:00 -0400 http://www.proactiveinvestors.com/companies/news/129072/bristol-myers-slumps-as-immunotherapy-drug-fails-lung-cancer-trial-129072.html Bristol Myers/ Janssen target lung cancer with I-O combo http://www.proactiveinvestors.com/companies/news/128646/bristol-myers-janssen-target-lung-cancer-with-i-o-combo-128646.html Tue, 26 Jul 2016 12:55:00 -0400 http://www.proactiveinvestors.com/companies/news/128646/bristol-myers-janssen-target-lung-cancer-with-i-o-combo-128646.html Bristol-Myers Squibb to get keys to Padlock http://www.proactiveinvestors.com/companies/news/124054/bristol-myers-squibb-to-get-keys-to-padlock-124054.html Wed, 23 Mar 2016 20:38:00 -0400 http://www.proactiveinvestors.com/companies/news/124054/bristol-myers-squibb-to-get-keys-to-padlock-124054.html Global drug industry profits set to slow, says Moody's http://www.proactiveinvestors.com/companies/news/123268/global-drug-industry-profits-set-to-slow-says-moody-s-123268.html Thu, 03 Mar 2016 15:00:00 -0500 http://www.proactiveinvestors.com/companies/news/123268/global-drug-industry-profits-set-to-slow-says-moody-s-123268.html Dual Therapeutics reports Bristol-Myers Squibb tie-up http://www.proactiveinvestors.com/companies/news/121125/dual-therapeutics-reports-bristol-myers-squibb-tie-up-121125.html Fri, 08 Jan 2016 13:29:00 -0500 http://www.proactiveinvestors.com/companies/news/121125/dual-therapeutics-reports-bristol-myers-squibb-tie-up-121125.html Bristol-Myers to take over Crioxyl Pharma in $2.1bn deal http://www.proactiveinvestors.com/companies/news/116957/bristol-myers-to-take-over-crioxyl-pharma-in-21bn-deal-116957.html Mon, 02 Nov 2015 13:26:00 -0500 http://www.proactiveinvestors.com/companies/news/116957/bristol-myers-to-take-over-crioxyl-pharma-in-21bn-deal-116957.html Bristol-Myers Squibb upgrades earnings guidance http://www.proactiveinvestors.com/companies/news/116728/bristol-myers-squibb-upgrades-earnings-guidance-116728.html Tue, 27 Oct 2015 16:37:00 -0400 http://www.proactiveinvestors.com/companies/news/116728/bristol-myers-squibb-upgrades-earnings-guidance-116728.html Bristol-Myers obtains rights to acquire drug developer Promedior for up to $1.25bn http://www.proactiveinvestors.com/companies/news/114569/bristol-myers-obtains-rights-to-acquire-drug-developer-promedior-for-up-to-125bn-114569.html Mon, 31 Aug 2015 16:43:00 -0400 http://www.proactiveinvestors.com/companies/news/114569/bristol-myers-obtains-rights-to-acquire-drug-developer-promedior-for-up-to-125bn-114569.html Bristol-Myers rises in premarket on JPMorgan upgrade http://www.proactiveinvestors.com/companies/news/97370/bristol-myers-rises-in-premarket-on-jpmorgan-upgrade-48065.html Mon, 16 Sep 2013 10:44:00 -0400 http://www.proactiveinvestors.com/companies/news/97370/bristol-myers-rises-in-premarket-on-jpmorgan-upgrade-48065.html Bristol-Myers Squibb Q4 results top views, shares rise http://www.proactiveinvestors.com/companies/news/92604/bristol-myers-squibb-q4-results-top-views-shares-rise-39781.html Thu, 24 Jan 2013 14:12:00 -0500 http://www.proactiveinvestors.com/companies/news/92604/bristol-myers-squibb-q4-results-top-views-shares-rise-39781.html Bristol-Myers Squibb posts Q3 loss on discontinued drug http://www.proactiveinvestors.com/companies/news/90670/bristol-myers-squibb-posts-q3-loss-on-discontinued-drug-36423.html Wed, 24 Oct 2012 14:11:00 -0400 http://www.proactiveinvestors.com/companies/news/90670/bristol-myers-squibb-posts-q3-loss-on-discontinued-drug-36423.html Bristol-Myers Squibb discontinues hepatitis C drug trial after patient death http://www.proactiveinvestors.com/companies/news/89006/bristol-myers-squibb-discontinues-hepatitis-c-drug-trial-after-patient-death-33803.html Fri, 24 Aug 2012 14:28:00 -0400 http://www.proactiveinvestors.com/companies/news/89006/bristol-myers-squibb-discontinues-hepatitis-c-drug-trial-after-patient-death-33803.html Bristol-Myers Squibb profit sheds 27% as patents expire http://www.proactiveinvestors.com/companies/news/88214/bristol-myers-squibb-profit-sheds-27-as-patents-expire-32461.html Wed, 25 Jul 2012 19:16:00 -0400 http://www.proactiveinvestors.com/companies/news/88214/bristol-myers-squibb-profit-sheds-27-as-patents-expire-32461.html Bristol-Myers rallies as it boosts stock buyback by $3 bln http://www.proactiveinvestors.com/companies/news/87394/bristol-myers-rallies-as-it-boosts-stock-buyback-by-3-bln-31103.html Wed, 27 Jun 2012 13:59:00 -0400 http://www.proactiveinvestors.com/companies/news/87394/bristol-myers-rallies-as-it-boosts-stock-buyback-by-3-bln-31103.html